Proactive Investors - Run By Investors For Investors

Valens GroWorks welcomes cannabis fund manager Everett Knight to its executive team

Everett Knight will fill the role of executive vice president of strategy and investments
Marijuana plants
The cannabis company specializes in the extraction of cannabinoids

Valens GroWorks Corp (CSE:VGW) (OTCQB: MYMSF) announced Everett Knight, a cannabis portfolio manager, joined its executive team, filling the role of executive vice president of strategy and investments.

Shares of the cannabis company were up more than 2% to US$1.19 by Thursday’s closing bell and had not yet begun trading in Toronto Friday morning.

READ: Valens GroWorks inks extraction agreement with Canopy Growth

Knight’s investment experience in the cannabis space dates back to 2014.

He has since evaluated hundreds of cannabis companies, according to the company, and has built up a knowledge base of the ins and outs of the budding industry.

"Everett is one of the leading Cannabis Portfolio Managers and has an exceptional investment track record with an in-depth knowledge of the cannabis industry," said Valens CEO Tyler Robson in the company’s press release.

"At Valens we strive to be the best in class premium extraction company globally and the addition of Everett will augment our top performing team,” he added.

The British Columbia-based company specializes in the extraction and purification of cannabinoids.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full VGW profile View Profile

Valens GroWorks Corporation Timeline

Related Articles

muffins and cannabis
November 29 2018
Dehydratech is essentially a delivery system that allows drugs and vitamins to get into the bloodstream quicker, while making them taste and smell better at the same time
A cannabis facility
December 02 2018
The Vancouver-based medicinal cannabis grower’s Queensland facility will be the world's largest greenhouse cannabis operation, covering a 99-acre site
medicinal cannabis concept
January 30 2019
Zelda has released its December quarterly report confirming multiple trials are on track.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use